![]() |
|
|
Vol. 294, Issue 2, 770-777, August 2000
1-Adrenergic-Mediated Responses in
Rat Ventricular Myocytes by Adenosine A1 Receptor
Activation: Role of the KATP Channel1
Department of Pharmacology and Toxicology, University of Western
Ontario, London, Ontario, Canada
Both
- and
1-adrenoceptors mediate the myocardial
effects of catecholamines. It is well known that adenosine inhibits
-dependent effects; however, whether
1-dependent
responses can be similarly modulated is unclear. Accordingly, rat
ventricular myocytes were exposed for 25 min to the
1
agonist phenylephrine (2 µM, in the presence of 1 µM propranolol)
in the absence or presence of adenosine (100 µM) or the
A1 receptor-selective agonist
N6-cyclopentyladenosine (CPA, 1 µM). We
also investigated the effects of KATP blockade with
glibenclamide (1 µM), the protein kinase C inhibitor
bisindolylmaleimide (20 nM), and pertussis toxin (300 ng/ml), which
uncouples Gi protein/receptor interaction, and assessed whether effects of adenosine were mimicked by KATP
activation with either pinacidil or cromakalim (5 µM). Phenylephrine
significantly increased cell shortening by 190% and the
Ca2+ transient by 24%, which was abolished by either
adenosine or CPA, but not in the presence of the A1
receptor-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (1 µM), and was abolished by pertussis toxin. The effect of adenosine or
CPA was reversed by glibenclamide and mimicked by either cromakalim or
pinacidil. Bisindolylmaleimide was without effect. The A2
or A3 receptor agonists
2-(4-(2-carboxyethyl)phenylethylamino)-5'-N-ethylcarboxamidoadenosine and
N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide
(1 µM each), respectively, were without effect. Neither CPA nor
adenosine modulated the effect of endothelin-1 (5 nM), which also acts
via the phosphoinositide hydrolysis pathway. We conclude that adenosine
selectively inhibits
1-adrenergic-mediated effects in
rat ventricular myocytes through a Gi protein-dependent
mechanism involving A1 receptor and KATP activation. Our study further suggests that endogenous adenosine may
modulate
1-mediated effects of catecholamines.
This article has been cited by other articles:
![]() |
A. K. Snabaitis, R. D'Mello, S. Dashnyam, and M. Avkiran A Novel Role for Protein Phosphatase 2A in Receptor-mediated Regulation of the Cardiac Sarcolemmal Na+/H+ Exchanger NHE1 J. Biol. Chem., July 21, 2006; 281(29): 20252 - 20262. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. T. Gan, V. Rajapurohitam, J. V. Haist, P. Chidiac, M. A. Cook, and M. Karmazyn Inhibition of Phenylephrine-Induced Cardiomyocyte Hypertrophy by Activation of Multiple Adenosine Receptor Subtypes J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran and R. S Haworth Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance Cardiovasc Res, March 15, 2003; 57(4): 942 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Varani, R. Manfredini, V. Iannotta, C. Pancaldi, E. Cattabriga, C. Uluoglu, P. A. Borea, and F. Portaluppi Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension Hypertension, December 1, 2002; 40(6): 909 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, X. T. Gan, J. V. Haist, Q. Feng, X. Lu, S. Chakrabarti, and M. Karmazyn Attenuation of Compensatory Right Ventricular Hypertrophy and Heart Failure following Monocrotaline-Induced Pulmonary Vascular Injury by the Na+-H+ Exchange Inhibitor Cariporide J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann, E. C. Skobel, H. Kammermeier, P. Hanrath, and E. R. Schwarz Activation of ATP-Sensitive Potassium Channels in Hypoxic Cardiac Failure Is not Mediated by Adenosine-1 Receptors in the Isolated Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 189 - 200. [Abstract] [PDF] |
||||